Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Real Estate Credit Investments maintains quarterly 3p dividend for 8 years (LON:RECI) 18 September 2025
Anglo American Plc and Teck agree merger, Target 70% copper exposure and $800m synergies 9 September 2025
Empiric Student Property reports £1.2bn portfolio value as Unite acquisition advances 9 September 2025
Unite Group publishes Scheme Document for Empiric Acquisition and Reports Strong Lettings 9 September 2025
Computacenter PLC (CCC.L): Navigating Growth and Valuation Challenges in the IT Services Sector 24 September 2025
Cranswick PLC (CWK.L): A Consumer Defensive Stock with Growth Potential Despite Valuation Challenges 24 September 2025
Bytes Technology Group PLC (BYIT.L): A Compelling Play in the Software Infrastructure Space 24 September 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Real Estate Credit Investments maintains quarterly 3p dividend for 8 years (LON:RECI) 18 September 2025
Anglo American Plc and Teck agree merger, Target 70% copper exposure and $800m synergies 9 September 2025
Empiric Student Property reports £1.2bn portfolio value as Unite acquisition advances 9 September 2025
Unite Group publishes Scheme Document for Empiric Acquisition and Reports Strong Lettings 9 September 2025
Computacenter PLC (CCC.L): Navigating Growth and Valuation Challenges in the IT Services Sector 24 September 2025
Cranswick PLC (CWK.L): A Consumer Defensive Stock with Growth Potential Despite Valuation Challenges 24 September 2025
Bytes Technology Group PLC (BYIT.L): A Compelling Play in the Software Infrastructure Space 24 September 2025
Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a Potential 171% Upside in the Gene Therapy Space 25 July 2025
Fulgent Genetics (FLGT) Stock Analysis: Unveiling a 23% Potential Upside in the Diagnostics Sector 25 July 2025
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Harnessing a 96.95% Potential Upside in Biotechnology 25 July 2025
Taysha Gene Therapies, Inc. (TSHA): Investor Outlook Reveals Stunning 222% Potential Upside 25 July 2025
Ardelyx, Inc. (ARDX) Stock Analysis: Exploring the 148% Potential Upside in Biotechnology 25 July 2025
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 277% Upside Potential in Biotech 25 July 2025
Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Potential 203.95% Upside in Biotech 25 July 2025
Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Strong Buy Ratings Signal Potential Upside of 40% 25 July 2025
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem with 163% Potential Upside 25 July 2025
Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Innovations in Medical Devices 25 July 2025
Nutex Health Inc. (NUTX) Stock Analysis: Unpacking a 159% Potential Upside with Robust Revenue Growth 25 July 2025
Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Exploring a 190% Potential Upside Through Gene Editing Innovation 25 July 2025
One Health Group Record Patient Growth and a Strategic Leap with New Surgical Hubs (Video) 27 June 2025
Playtech reports H1 2025 results, delivers strong B2B growth and €1.8bn shareholder payout 11 September 2025
Vistry Group Plc reports H1 results with debt reduction and affordable housing focus 10 September 2025
Real Estate Credit Investments maintains quarterly 3p dividend for 8 years (LON:RECI) 18 September 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Computacenter PLC (CCC.L): Navigating Growth and Valuation Challenges in the IT Services Sector 24 September 2025
Cranswick PLC (CWK.L): A Consumer Defensive Stock with Growth Potential Despite Valuation Challenges 24 September 2025
Bytes Technology Group PLC (BYIT.L): A Compelling Play in the Software Infrastructure Space 24 September 2025
